Articles

MyMD Pharmaceuticals just reported results for the fourth quarter of 2023. More

AYRO stock results show that AYRO missed analyst estimates for earnings per share the first quarter of 2024. More

While Canopy Growth is in the news thanks to marijuana’s reclassification proposal, CGC stock carries questions ahead of earnings. More

Tiger Global has disclosed a 500,000 share stake in RDDT stock. The hedge fund purchased shares shortly after the IPO. More

Explore the growth prospects of hidden stocks to buy with their paths to dominance in technology hardware, applications and systems software. More

Here are five things investors should watch as we come into what will surely be a very busy week ahead in stocks. More

For investors looking to don their Dow 40,000 hats, we may be nearing the day this index closes above that key psychological level. More

Subscriber Sign in